Stalled at the intersection: insurance status and disparities in post-mastectomy breast reconstruction.


Journal

Breast cancer research and treatment
ISSN: 1573-7217
Titre abrégé: Breast Cancer Res Treat
Pays: Netherlands
ID NLM: 8111104

Informations de publication

Date de publication:
Jul 2022
Historique:
received: 13 08 2021
accepted: 24 05 2022
pubmed: 15 6 2022
medline: 1 7 2022
entrez: 14 6 2022
Statut: ppublish

Résumé

Post-mastectomy breast reconstruction (PMBR) is an important component of breast cancer treatment, but disparities relative to insurance status persist despite legislation targeting the issue. We aimed to study this relationship in a large health system combining a safety-net hospital and a private academic center. Data were collected on all patients who underwent mastectomy for breast cancer from 2011 to 2019 in a private academic center and an adjacent public safety-net hospital served by the same surgical teams. Multivariable logistic regression was used to assess the effect of insurance status on PMBR, controlling for covariates that included socioeconomic, demographic, and clinical factors. Of 1554 patients undergoing mastectomy for breast cancer, 753 (48.5%) underwent PMBR, of which 592 (79.9%) were privately insured, 50 (6.7%) Medicare, 68 (9.2%) Medicaid, and 31 (4.2%) uninsured. Multivariable logistic regression showed a significantly higher likelihood of not undergoing PMBR for uninsured (OR 6.0, 95% CI 3.7-9.8; p < 0.0001), Medicare (OR 1.9, (95% CI 1.2-3.0; p = 0.006), and Medicaid (OR 1.5, 95% CI 1.0-2.3; p = 0.04) patients compared with privately insured patients. Age, stage, race and ethnicity, and hospital type confounded this relationship. Patients without health insurance have dramatically reduced access to PMBR compared to those with private insurance. Expanding access to this important procedure is essential to achieve greater health equity for breast cancer patients.

Identifiants

pubmed: 35699853
doi: 10.1007/s10549-022-06639-8
pii: 10.1007/s10549-022-06639-8
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

327-335

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Références

Surveillance, Epidemiology, and End Results Program. Cancer Stat Facts: Female Breast Cancer. National Cancer Institute. Updated (2020). https://seer.cancer.gov/statfacts/html/breast.html Accessed 17 Nov 2020
Kummerow KL, Du L, Penson DF et al (2015) Nationwide trends in mastectomy for early-stage breast cancer. JAMA Surg 150:9–16. https://doi.org/10.1001/jamasurg.2014.2895
doi: 10.1001/jamasurg.2014.2895 pubmed: 25408966
Mahmood U, Hanlon AL, Koshy M et al (2013) Increasing national mastectomy rates for the treatment of early stage breast cancer. Ann Surg Oncol 20:1436–1443. https://doi.org/10.1245/s10434-012-2732-5
doi: 10.1245/s10434-012-2732-5 pubmed: 23135312
Cagli B, Cogliandro A, Barone M, Persichetti P (2014) Quality-of-life outcomes between mastectomy alone and breast reconstruction: comparison of patient-reported BREAST-Q and other health-related quality-of-life measures. Plast Reconstr Surg 133(4):594e–595e. https://doi.org/10.1097/PRS.0000000000000031
doi: 10.1097/PRS.0000000000000031 pubmed: 24675212
Fanakidou I, Zyga S, Alikari V et al (2018) Mental health, loneliness, and illness perception outcomes in quality of life among young breast cancer patients after mastectomy: the role of breast reconstruction. Qual Life Res 27:539–543. https://doi.org/10.1007/s11136-017-1735-x
doi: 10.1007/s11136-017-1735-x pubmed: 29119452
Markopoulos C, Tsaroucha AK, Kouskos E et al (2009) Impact of breast cancer surgery on the self-esteem and sexual life of female patients. J Int Med Res 37:182–188. https://doi.org/10.1177/147323000903700122
doi: 10.1177/147323000903700122 pubmed: 19215689
Dauplat J, Kwiatkowski F, Rouanet P et al (2017) Quality of life after mastectomy with or without immediate breast reconstruction. Br J Surg 104:1197–1206. https://doi.org/10.1002/bjs.10537
doi: 10.1002/bjs.10537 pubmed: 28401542
Keith DJ, Walker MB, Walker LG et al (2003) Women who wish breast reconstruction: characteristics, fears, and hopes. Plast Reconstr Surg 111:1051–1056. https://doi.org/10.1097/01.PRS.0000046247.56810.40 (Discussion 1057–1059)
doi: 10.1097/01.PRS.0000046247.56810.40 pubmed: 12621174
Alderman AK, McMahon L Jr, Wilkins EG (2003) The national utilization of immediate and early delayed breast reconstruction and the effect of sociodemographic factors. Plast Reconstr Surg 111:695–703. https://doi.org/10.1097/01.PRS.0000041438.50018.02 (Discussion 704–695)
doi: 10.1097/01.PRS.0000041438.50018.02 pubmed: 12560690
Centers for Medicare & Medicaid Services: Breast Reconstruction Following Mastectomy (NCD 140.2) (1997) https://www.cms.gov/medicare-coverage-database/details/ncd-details.aspx?NCDId=64&ncdver=1&bc=AgAAQAAAAAAAAA%3D%3D Accessed 17 Nov 2020
USA Congress (1998) Women’s Health and Cancer Rights Act. H.R. 616, 105th Cong. https://www.congress.gov/bill/105th-congress/house-bill/616 Accessed 17 Nov 2020
Florida Senate (2016) Senate Bill 876: insurance coverage for devices incident to mastectomy. Statute 627.6417. https://www.flsenate.gov/Session/Bill/2016/876/BillText/Filed/HTML . Accessed 17 Nov 2020
Xie Y, Tang Y, Wehby GL (2015) Federal health coverage mandates and health care utilization: the case of the women’s health and cancer rights act and use of breast reconstruction surgery. J Womens Health (Larchmt) 24:655–662. https://doi.org/10.1089/jwh.2014.5057
doi: 10.1089/jwh.2014.5057
Shippee TP, Kozhimannil KB, Rowan K, Virnig BA (2014) Health insurance coverage and racial disparities in breast reconstruction after mastectomy. Womens Health Issues 24:e261-269. https://doi.org/10.1016/j.whi.2014.03.001
doi: 10.1016/j.whi.2014.03.001 pubmed: 24794541 pmcid: 4100699
Butler PD, Familusi O, Serletti JM, Fox JP (2018) Influence of race, insurance status, and geographic access to plastic surgeons on immediate breast reconstruction rates. Am J Surg 215:987–994. https://doi.org/10.1016/j.amjsurg.2017.09.037
doi: 10.1016/j.amjsurg.2017.09.037 pubmed: 29103529
Christian CK, Niland J, Edge SB et al (2006) (2006) A multi-institutional analysis of the socioeconomic determinants of breast reconstruction: a study of the national comprehensive cancer network. Ann Surg 243:241–249. https://doi.org/10.1097/01.sla.0000197738.63512.23
doi: 10.1097/01.sla.0000197738.63512.23 pubmed: 16432358 pmcid: 1448910
Coburn N, Fulton J, Pearlman DN et al (2008) Treatment variation by insurance status for breast cancer patients. Breast J 14:128–134. https://doi.org/10.1111/j.1524-4741.2007.00542.x
doi: 10.1111/j.1524-4741.2007.00542.x pubmed: 18315690
Sisco M, Du H, Warner JP et al (2012) Have we expanded the equitable delivery of postmastectomy breast reconstruction in the new millennium? Evidence from the national cancer data base. J Am Coll Surg 215:658–666. https://doi.org/10.1016/j.jamcollsurg.2012.07.008 (Discussion 666)
doi: 10.1016/j.jamcollsurg.2012.07.008 pubmed: 22921327
von Elm E, Altman DG, Egger M et al (2014) The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 12:1495–1499. https://doi.org/10.1016/j.ijsu.2014.07.013
doi: 10.1016/j.ijsu.2014.07.013
HartFunderburk ACD, Chu CK et al (2017) The impact of diabetes mellitus on wound healing in breast reconstruction. Ann Plast Surg 78:260–263. https://doi.org/10.1097/SAP.0000000000000881
doi: 10.1097/SAP.0000000000000881
Fischer JP, Wes AM, Kanchwala S, Kovach SJ (2014) Effect of BMI on modality-specific outcomes in immediate breast reconstruction (IBR)—a propensity-matched analysis using the 2005–2011 ACS-NSQIP datasets. J Plast Surg Hand Surg 48:297–304. https://doi.org/10.3109/2000656X.2013.877915
doi: 10.3109/2000656X.2013.877915 pubmed: 24443774
In H, Jiang W, Lipsitz SR et al (2013) Variation in the utilization of reconstruction following mastectomy in elderly women. Ann Surg Oncol 20:1872–1879. https://doi.org/10.1245/s10434-012-2821-5
doi: 10.1245/s10434-012-2821-5 pubmed: 23263733
McCarthy CM, Mehrara BJ, Riedel E et al (2008) Predicting complications following expander/implant breast reconstruction: an outcomes analysis based on preoperative clinical risk. Plast Reconstr Surg 121:1886–1892. https://doi.org/10.1097/PRS.0b013e31817151c4
doi: 10.1097/PRS.0b013e31817151c4 pubmed: 18520873
US Census Bureau. Income statistics for florida zip codes. Florida, USA. https://www.incomebyzipcode.com/florida . Accessed 17 Nov 2020
Mayhew D, Mendonca V, Murthy BVS (2019) A review of ASA physical status—historical perspectives and modern developments. Anaesthesia 74:373–379. https://doi.org/10.1111/anae.14569
doi: 10.1111/anae.14569 pubmed: 30648259
Giuliano AE, Edge SB, Hortobagyi GN (2018) Eighth edition of the AJCC cancer staging manual: breast cancer. Ann Surg Oncol 25(7):1783–1785. https://doi.org/10.1245/s10434-018-6486-6
doi: 10.1245/s10434-018-6486-6 pubmed: 29671136
Rusthoven CG, Rabinovitch RA, Jones BL et al (2016) The impact of postmastectomy and regional nodal radiation after neoadjuvant chemotherapy for clinically lymph node-positive breast cancer: a National Cancer Database (NCDB) analysis. Ann Oncol 27(5):818–827. https://doi.org/10.1093/annonc/mdw046
doi: 10.1093/annonc/mdw046 pubmed: 26861597
Yun JH, Diaz R, Orman AG (2018) Breast reconstruction and radiation therapy. Cancer Control 25(1):1073274818795489. https://doi.org/10.1177/1073274818795489
doi: 10.1177/1073274818795489 pubmed: 30132338 pmcid: 6108018
Flegal KM, Kit BK, Orpana H, Graubard BI (2013) Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 309:71–82. https://doi.org/10.1001/jama.2012.113905
doi: 10.1001/jama.2012.113905 pubmed: 23280227 pmcid: 4855514
Kruper L, Holt A, Xu XX et al (2011) Disparities in reconstruction rates after mastectomy: patterns of care and factors associated with the use of breast reconstruction in Southern California. Ann Surg Oncol 18:2158–2165. https://doi.org/10.1245/s10434-011-1580-z
doi: 10.1245/s10434-011-1580-z pubmed: 21308486
Niu X, Roche LM, Pawlish KS, Henry KA (2013) Cancer survival disparities by health insurance status. Cancer Med 2:403–411. https://doi.org/10.1002/cam4.84
doi: 10.1002/cam4.84 pubmed: 23930216 pmcid: 3699851
Schwartz DA, Hui X, Schneider EB et al (2014) Worse outcomes among uninsured general surgery patients: does the need for an emergency operation explain these disparities? Surgery 156:345–351. https://doi.org/10.1016/j.surg.2014.04.039
doi: 10.1016/j.surg.2014.04.039 pubmed: 24953267
McMorrow S, Long SK, Kenney GM, Anderson N (2015) Uninsurance disparities have narrowed for black and hispanic adults under the affordable care act. Health Aff (Millwood) 34(10):1774–1778
doi: 10.1377/hlthaff.2015.0757
Neuhausen K, Davis AC, Needleman J et al (2014) Disproportionate-share hospital payment reductions may threaten the financial stability of safety-net hospitals. Health Aff (Millwood) 33:988–996. https://doi.org/10.1377/hlthaff.2013.1222
doi: 10.1377/hlthaff.2013.1222
Hoehn RS, Wima K, Vestal MA et al (2016) Effect of hospital safety-net burden on cost and outcomes after surgery. JAMA Surg 151:120–128. https://doi.org/10.1001/jamasurg.2015.3209
doi: 10.1001/jamasurg.2015.3209 pubmed: 26466334
Hershman DL, Richards CA, Kalinsky K et al (2012) Influence of health insurance, hospital factors and physician volume on receipt of immediate post-mastectomy reconstruction in women with invasive and non-invasive breast cancer. Breast Cancer Res Treat 136:535–545. https://doi.org/10.1007/s10549-012-2273-4
doi: 10.1007/s10549-012-2273-4 pubmed: 23053659 pmcid: 3651032
Alderman AK, Hawley ST, Janz NK et al (2009) Racial and ethnic disparities in the use of postmastectomy breast reconstruction: results from a population-based study. J Clin Oncol 27:5325–5330. https://doi.org/10.1200/JCO.2009.22.2455
doi: 10.1200/JCO.2009.22.2455 pubmed: 19805680 pmcid: 2773218
Hong KY, Son Y, Chang H, Jin US (2018) Trends in breast reconstruction: implications for the national health insurance service. Arch Plast Surg 45:239–245. https://doi.org/10.5999/aps.2017.01417
doi: 10.5999/aps.2017.01417 pubmed: 29788687 pmcid: 5968321

Auteurs

Orli Friedman-Eldar (O)

Breast Surgical Oncology Department, Jackson Memorial Hospital, Miami, FL, USA. eldaror@gmail.com.
Breast surgical Oncology Department, Kaplan Medical Center, Rehovot, Israel. eldaror@gmail.com.

Jonathan Burke (J)

Department of Surgery, New York University School of Medicine, NewYork, NY, USA.
University of Miami, Miller School of Medicine, Miami, FL, USA.

Iago de Castro Silva (I)

Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.

Camille C Baumrucker (CC)

University of Miami, Miller School of Medicine, Miami, FL, USA.

Fernando Valle (F)

University of Miami, Miller School of Medicine, Miami, FL, USA.
University of El Salvador, San Salvador, El Salvador.

Anne-Sophie Lessard (AS)

Division of Plastic Surgery, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.

Wrood Kassira (W)

Division of Plastic Surgery, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.

Dido Franceschi (D)

Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.

Susan B Kesmodel (SB)

Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.

Eli Avisar (E)

Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.

Neha Goel (N)

Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.

Mecker G Möller (MG)

Division of Surgical Oncology, DeWitt Daughtry Family Department of Surgery, University of Miami Miller School of Medicine, Miami, FL, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH